Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Urine, DNA and Retrospective Clinical Information Collection From Patients With Alport Nephropathy.

NCT03074357 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT03074357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03074357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Urine, DNA and Retrospective Clinical Information Collection From Patients With Alport Nephropathy.
Lead sponsor
Novartis Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
April 4, 2017
Completion date
March 23, 2018
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alport nephropathy